Compliance and persistence with osteoporosis medications: A critical review of the literature

Reviews in Endocrine and Metabolic Disorders

Volumn 11, Issue 4, 2010, Pages 275-280

  Silverman, Stuart ^a   Gold, Deborah T ^b  

^a UNIVERSITY OF CALIFORNIA   (United States)

^b DUKE UNIVERSITY MEDICAL CENTER   (United States)

Author keywords

Adherence; Compliance; Osteoporosis; Persistence

Indexed keywords

ALCOHOL; ALENDRONIC ACID; ANTIHYPERTENSIVE AGENT; BETA ADRENERGIC RECEPTOR BLOCKING AGENT; BISPHOSPHONIC ACID DERIVATIVE; CALCIUM CHANNEL BLOCKING AGENT; IBANDRONIC ACID; ORAL ANTIDIABETIC AGENT; RISEDRONIC ACID; STATIN; BONE DENSITY CONSERVATION AGENT;

DIABETES MELLITUS; DRUG COST; ETHNICITY; FEAR; FRACTURE; HUMAN; HYPERTENSION; INSURANCE; OSTEOPOROSIS; PATIENT ATTITUDE; PATIENT COMPLIANCE; PHYSICIAN ATTITUDE; POSTMENOPAUSE; RACE; REVIEW; RISK ASSESSMENT; ROLE PLAYING; UNSPECIFIED SIDE EFFECT; VITAMIN D DEFICIENCY;

BONE DENSITY CONSERVATION AGENTS; HUMANS; MEDICATION ADHERENCE; OSTEOPOROSIS;

EID: 79953224244     PISSN: 13899155     EISSN: 15732606     Source Type: Journal    
DOI: 10.1007/s11154-010-9138-0     Document Type: Review

References (32)

1. Siris ES, Harris ST, Rosen CJ, et al. Adherence to bisphosphonate therapy and fracture rates in osteoporotic women: relationship to vertebral and nonvertebral fractures from 2 US claims databases. Mayo Clin Proc. 2006;81:1013-22.
2. Huybrechts KF, Ishak KJ, Caro JJ. Assessment of compliance with osteoporosis treatment and its consequences in a managed care population. Bone. 2006;38:922-8. (Pubitemid 44498580)
3. Rabenda V, Mertens R, Fabri V, Vanoverloop J, Sumkay F, Vannecke C, et al. Adherence to bisphosphonates therapy and hip fracture risk in osteoporotic women. Osteoporos Int. 2008;19:811-8.
4. Granger BB, Swedberg K, Ekman I, et al. Adherence to candesartan and placebo and outcomes in chronic renal failure in the CHARM program, double-blind randomized controlled trial. Lancet. 2005;366:2005-11. (Pubitemid 41773375)
5. Rasmussen JIN, Chong A, Alter DA. 2007 Relationship between adherence to evidence-based pharmacotherapy and long term mortality of people with myocardial infarctions. JAMA. 2007;297(2):177-86. (Pubitemid 46089734)
6. Holick MF. Vitamin D deficiency. N Engl J Med. 2007;357:266-81.
7. Curtis J, Larson J, Delzell E, Judd S, Safford MM, LaCroix A, et al. Does the benefit of medication adherence relate more to a drug effect or the behavior Itself? Quantifying the effect of adherence behavior using data from the placebo arms of the WHI. [abstract]. Arthritis Rheum. 2009;60 Suppl 10:613. doi:10.1002/art.25693.
8. Silverman SL, Cramer JA, Sunyecz JA, et al (2007) Women are more persistent with monthly bisphosphonate therapy compared to weekly bisphosphonates: 12 month results from two retrospective databases. Presented at ASBMR Montreal Sept 19, 2007. Abstract W366.
9. Gold DT, Safi W, Trinh H. Patient preference and adherence: comparative US studies between two bisphosphonates, weekly risedronate and monthly ibandronate. Curr Med Res Opin. 2006;22:2383-91. (Pubitemid 46055201)
10. Griswold ME, Localio AR, Mulrow C. Propensity score adjustment with multilevel data: setting your sites on decreasing selection bias. Ann Int Med. 2010;152:393-5.
11. Hamilton B, McCoy K, Taggart H. Tolerability and compliance with risedronate in clinical practice. Osteoporos Int. 2003;14:259-62. (Pubitemid 40826240)
12. Kennedy J, Teleu I, Mackay K. Unfilled prescriptions of Medicare beneficiaries: prevalence, reasons, and types of medicines prescribed. J Manage Care Pharm. 2008;14:553-60.
13. Fischer MA, Stedman MR, Lii J, et al. Primary medication nonadherence analysis: analysis of 195, 930 electronic prescriptions. J Gen Intern Med. 2010;25(4):284-90. doi:10.1007/s11606-010-1253-9.
14. Boston Consulting Group (BCG) (2002) Analysis: Harris Interactive 10,000 Patient Survey 2002 at http://www.bcg.com/documents/file14265.pdf accessed October 21,2009.
15. Rees, G., Leong, O., Crowston, J. C. Intentional and Unintentional Nonadherence to Ocular or Hypertensive Treatment in Patients with Glaucoma, Ophthalmology, 2010, doi:10.1016/j.ophtha.2009.10.038.
16. Clifford S, Barber N, Home R. Understanding different beliefs held by adherers, unintentional non-adherers and intentional nonadherers, applications and necessity-concerns framework. J Psychosom Res. 2008;64:41-6. (Pubitemid 350297299)
17. Christensen AJ, Howren MB, Hillis SL, Kaboli P, Carter BL, Cvengros JA, Wallston KA, Rosenthal GE. Patient and physician beliefs about control over health: association of symmetrical beliefs with medication regimen adherence. J Gen Intern Med. 2010;25(5):397-402.
18. Gusdal AK, Obua C, Andaulem T, et al. Voices on adherence to ART in Ethiopia and Uganda: a matter of choice or simply not an option. AIDS Care. 2009;21:1381-7.
19. Trinacty CM, Adams AS, Soumerai SB, et al. Racial differences in long term adherence to oral antidiabetic drug theraphy: a longitudinal cohort study. BMC Health Services Research 2009;9:24-34. doi:10.1186/1472-6963-9-24.
20. Cramer JA. Systematic review of adherence with medicines for diabetes. Diabetes Care. 2004;2712:18-24.
21. Van den Bemt BJ, van den Hoogen FH, Benraad B, et al. Adherence rates and associations with nonadherence in patients with rheumatoid arthritis using disease modifying antirheumatic drugs. J Rheumatol. 2009;36:2164-70.
22. Zivin K, Ganoczy D, Pfeiffer PN, Miller EM, Valenstein M. Antidepressant adherence after psychiatric hospitalization among VA patients with depression. Admin Pol Ment Health. 2009;36(6):406-15.
23. Cizza G, Primma S, Csako G. Depression as a risk factor for osteoporosis. Trends Endocrinol Metabol. 2009;20(8):367-73.
24. Buist DS, LaCroix AZ, Black DM, Harris F, Blank J, Ensrud K, et al. Inclusion of older women in randomized clinical trials: factors associated with taking study medication in the fracture intervention trial. J Am Geriatr Soc. 2000;48(9):1126-31.
25. Bazargan JKH, Bing EG M. Alcohol consumption and compliance among inner-city minority patients with type 2 diabetes mellitus. Arch Fam Med. 2000;9(10):964-70.
26. Bryson CL, Au DH, et al. Alcohol screening scores and medication non-adherence. Ann Intern Med. 2008;149:795-804.
27. Thiebaud P, Patel BV, Nichol MB, Berenbeim DM. The effect of switching on compliance and persistence: the case of statin treatment. Am J Manag Care. 2005;11:670-74. (Pubitemid 41608208)
28. Haynes RB, Ackloo E, Sahota N, McDonald HP, Yao X. Interventions for enhancing medication adherence. Cochrane Database Syst Rev. 2008;16(2):CD000011.
29. Conn VS, Hafdahl AR, Cooper PS, Ruppar TM, Mehr DR, Russell CL. Interventions to improve medication adherence among older adults: meta-analysis of adherence outcomes among randomized controlled trials. Gerontologist. 2009;49(4):447-62.
30. Russell CL. A clinical nurse specialist-led intervention to enhance medication adherence using the plan-do-check-act cycle for continuous self-improvement. Clin Nurse Spec. 2010;24(2):69-75.
31. Schackman BR, Dastin Z, Rubin DS. Feasibility of using audio computer assisted self interview (ACASI) screening in routine HIV care. AIDS Care. 2009;21:992-9.
32. Wilson Sr , Stroub P, Buist AS, et al. Shared treatment decision making improves adherence and outcomes in poorly controlled asthma. Am J Respir Crit Care Med. 2010;181:566-77.